Over the last decades, transcriptome profiling emerged as one of the most powerful
approaches in oncology, providing prognostic and predictive utility for cancer management …

Background Molecular tests are being used increasingly as an auxiliary diagnostic tool so
as to avoid a diagnostic surgery approach for cytologically indeterminate thyroid nodules …

Objective: To develop evidence-based recommendations for safe, effective, and appropriate
thyroidectomy. Background: Surgical management of thyroid disease has evolved …

Thyroid nodules are extremely common and can be detected by sensitive imaging in more
than 60% of the general population. They are often identified in patients without symptoms …

Fluorescence polarization (Fpol) imaging of methylene blue (MB) is a promising quantitative
approach to thyroid cancer detection. Clinical translation of MB Fpol technology requires …

Thyroid cancer is the most common endocrine malignancy with an estimated 43,800 new
cases to be diagnosed in 2022 and representing the 7th most common cancer in women …

Molecular testing contributes to improving the diagnosis of indeterminate thyroid nodules
(ITNs). ThyroidPrint® is a ten-gene classifier aimed to rule out malignancy in ITN. Post …

Simple Summary The aim of this review is to provide a general overview about the
molecular markers (mutations and alterations) of thyroid cancers, present several molecular …

Aim: To clinically validate the 40-gene expression profile (40-GEP) test for cutaneous
squamous cell carcinoma patients and evaluate coupling the test with individual …

Differentiated thyroid carcinoma (DTC) is the most common endocrine cancer. Particularly
the incidence of small clinically indolent tumors has been increasing significantly during the …